National Drug Schedules

Drug Name

Comments

Schedule

Date

When sold in oral, fixed-dose combinations, in package sizes containing either more than 20,000 mg of acetaminophen or more than 6,000 mg of ibuprofen* *Note that this listing does not apply to products containing ibuprofen that would meet the criteria to be included on the Prescription Drug list, as these would require a prescription
II
Jul / 20
When sold in oral, fixed-dose combinations, in package sizes containing 20,000 mg or less of acetaminophen and 6,000 mg or less of ibuprofen* *Note that this listing does not apply to products containing ibuprofen that would meet the criteria to be included on the Prescription Drug list, as these would require a prescription
III
Jul / 20
up to and including 650 mg per unit, in package sizes containing no more than 50 units
U
Jan / 03
when recommended for administration by intravenous injection
I
Dec / 13
in strengths of greater than 650 mg per unit or in package sizes of more than 50 units
III
Jan / 03
in immediate release tablets, capsules, suppositories or liquid
U
Sep / 99

Footnotes

C – Drug is listed in the Schedule to Part G of the Food and Drug Regulations under the Controlled Drugs and Substances Act
CR – Drug has been recommended for addition to the Controlled Drugs and Substances Act
N – Drug is listed in the Narcotic Control Regulations under the Controlled Drugs and Substances Act
NR – Drug has not been reviewed by the NDSAC
PDL – Drug is listed in the Health Canada Prescription Drug List
TS – Drug is listed in the Benzodiazepines and Other Targeted Substances Regulations under the Controlled Drugs and Substances Act